China, Nov. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective Cohort Study on Multimodal Data of Propofol-Remifentanil Target-Controlled Infusion in Breast Surgery Patients'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136530
Registration Time: 2026/11/11
Type: Observational study
Primary Sponsor: The First Medical Center of Chinese PLA General Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=350486
Published by HT Digital Content Services with permission from Health Daily Digest....